DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Maurer MJ, Habermann TM, Shi Q. et al.
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials.
Ann Oncol 2018;
29: 1822-1827
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.